FDA Authorizes Pfizer Covid Booster Shot for People 65 and Older and “High Risk” Americans
That was quick.
The FDA on Wednesday approved a Pfizer Covid booster shot for people ages 65 and up and high risk Americans.
“The FDA considered the committee’s input and conducted its own thorough review of the submitted data to reach today’s decision,” Dr. Peter Marks, the agency’s top vaccine regulator, said in a statement. “We will continue to analyze data submitted to the FDA pertaining to the use of booster doses of COVID-19 vaccines and we will make further decisions as appropriate based on the data.”
CNBC reported:
The Food and Drug Administration authorized Pfizer and BioNTech’s Covid-19 booster shots for people 65 and older and other vulnerable Americans, in line with recommendations given Friday by its key vaccine advisory committee.
